REGN
Regeneron Pharmaceuticals Inc
742.10$
+0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -84.2% | -18.4% | -26.7% | -40.0% | -47.1% | -260.9% | -502.7% | -10.7% | -9.7% | -45.8% | 36.4% | 21.9% | -37.4% | -19.0% | 21.0% | -31.8% | -5.4% | 28.0% | 26.7% | 32.4% | 30.6% | 22.3% | 32.7% | 30.9% | 30.8% | 44.1% | 41.2% | 35.0% | 31.1% | 34.7% | |
| 25.3% | 13.3% | 7.9% | 9.9% | 7.5% | 27.7% | 38.4% | 22.5% | 8.8% | 23.4% | 23.0% | 9.2% | 4.7% | 3.8% | 4.3% | 7.0% | 2.7% | 2.0% | 1.9% | 1.8% | 2.2% | 2.5% | 2.2% | 2.7% | 2.8% | 1.8% | 2.8% | 3.2% | 3.4% | 3.8% | |
| – | – | – | – | – | – | – | – | – | – | – | 22.5% | 13.6% | 8.2% | 8.7% | 12.6% | 6.8% | 9.4% | 10.9% | 11.2% | 11.5% | 8.6% | 6.4% | 5.9% | 5.1% | 3.7% | 6.0% | 6.7% | 6.9% | 6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 43.7% | 18.0% | -59.8% | 7.6% | 14.0% | 16.9% | 11.9% | 1.8% | -3.7% | 4.0% | -10.5% | -6.2% | 5.6% | – | – | – | |
| -35.3% | -7.9% | -19.4% | 3.5% | -25.7% | 50.1% | 16.3% | 146.7% | -33.8% | 42.0% | 146.5% | 70.0% | -22.0% | -13.0% | 30.7% | -3.9% | -48.8% | -9.1% | 0.7% | 5.6% | 4.7% | -15.8% | -10.4% | -2.5% | -17.7% | -11.9% | -2.0% | -0.7% | -4.4% | 3.7% | |
| 35.7% | 6.3% | 7.9% | 16.5% | 11.0% | 37.4% | 156.3% | 51.6% | 3.5% | 7.5% | 4.4% | 14.8% | 14.6% | 25.7% | 21.7% | 12.8% | 3.6% | 7.4% | 11.8% | 16.5% | 10.5% | 4.6% | 5.7% | 5.5% | 7.2% | 3.4% | 4.8% | 7.1% | 5.3% | 6.3% | |
| -183.8% | -117.5% | 6.3% | 50.7% | -97.3% | -343.1% | -266.1% | -111.0% | -2.6% | 174.5% | -244.5% | -68.6% | 12.9% | 0.0% | -94.6% | 28.8% | -5.9% | -16.9% | -14.9% | -22.1% | -21.5% | -17.1% | -21.8% | -25.8% | -0.8% | -33.5% | -31.1% | -24.3% | -17.4% | -4.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 10.4% | 13.3% | 10.3% | 6.1% | – | – | – | – | – | 0.0% | 0.0% | 2.6% | |
| – | – | – | – | – | – | – | – | -0.5% | – | – | – | – | – | -0.8% | -5.6% | -11.8% | -9.3% | -9.5% | -3.9% | -2.9% | -5.1% | -2.9% | -5.9% | -76.8% | -16.7% | -20.8% | -17.0% | -25.6% | -27.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | -26.6% | -0.2% | -0.1% | -7.9% | -3.4% | -0.8% | 0.6% | 29.5% | 25.2% | 23.3% | 0.0% | 0.0% | – | – | – | |
| 275.1% | 119.0% | -3.7% | 0.9% | 156.7% | 1,588.9% | 7.8% | 188.2% | 2.6% | 6.2% | 292.2% | 255.5% | -80.9% | 8.3% | 53.0% | 86.2% | -7.1% | 3.4% | -7.8% | -6.4% | -14.4% | -0.4% | -1.1% | -3.2% | -23.2% | -6.3% | -8.3% | -13.6% | -15.5% | -25.9% | |
| 7.1% | -16.9% | -24.1% | 11.3% | 12.3% | 984.9% | -760.9% | 66.5% | -9.8% | 134.9% | 84.1% | 208.8% | -105.3% | -10.7% | -20.6% | 83.2% | -18.4% | 14.5% | 4.0% | 3.9% | -5.6% | 4.7% | 9.8% | 1.9% | 6.8% | 4.3% | 1.8% | -2.9% | -1.8% | 4.4% | |
| -119.9% | -24.8% | -34.6% | -56.5% | -58.0% | -298.3% | -659.0% | -62.2% | -13.3% | -53.3% | 31.9% | 7.1% | -52.0% | -44.7% | -0.7% | -44.6% | -9.0% | 20.5% | 14.9% | 15.9% | 20.0% | 17.6% | 27.0% | 25.4% | 23.6% | 40.6% | 36.3% | 28.0% | 25.8% | 28.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.